Cannabis Council of Canada adds industry veteran and Sensi Brands’ CEO Tony Giorgi to its Board
July 15, 2021 - Ottawa, ON - The Cannabis Council of Canada (“C3”) is pleased to announce the addition of Mr. Tony Giorgi, founder and CEO of Sensi Brands Inc. (“Sensi Brands”), to its board of directors. Mr. Giorgi’s executive suite experience in the information technology sector and his previous cannabis industry experience as the founding CEO of The Flowr Corp, bring proven expertise in technology, manufacturing, and licensed cannabis to C3’s leadership.
“On behalf of C3’s Board of Directors, I wish to extend a warm welcome to Mr. Giorgi” said Mr. Rick Savone Chair of the C3 Board and Senior Vice President, Global Government Relations, Aurora Cannabis. “Tony’s 25+ years of business experience, as both a founder and an executive of many successful businesses, will help C3 advocate for the changes needed to support the success of Canada’s licensed cannabis companies and the accomplishment of legalization’s public policy objectives,” he concluded.
“I am grateful to have the opportunity to join C3’s board and look forward to working with my fellow board members on the challenges and opportunities facing Canada’s cannabis industry as it prepares for and participates in the critically important legislative review of the Cannabis Act ,” said Mr. Giorgi.
Based in St. Thomas, Ontario, Sensi Brands Inc. is a licensed cannabis cultivation, processing, and consumer packaged goods company. Sensi Brands operates four lines of business servicing the Canadian cannabis industry including: wholesale product distribution, a consumer brands portfolio, a medical marketplace, and a full-service medical cannabis clinic.
About the Cannabis Council of Canada
The Cannabis Council of Canada is the national organization of cannabis licensees on record with Health Canada advocating on behalf of the licensed cannabis industry. C3’s mission is to act as a national voice for our members in the promotion of industry standards; support the development, growth and integrity of the regulated cannabis industry; and to serve as an important resource on issues related to the safe and responsible use of cannabis for medical and non-medical purposes.
General and media inquiries can be directed to:
President and CEO